Primary adenocarcinoma of the fallopian tube. Review of the literature

Baekelandt, M.; Kockx, Mark; Wesling, F.; Gerris, Jan

doi:10.1046/j.1525-1438.1993.03020065.x

Cited by 50 publications

(36 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vaughan et al [46] reported a rate of 21% of preoperative diagnosis, Baekelandt et al [28] reported a rate of only 2%, and Meng et al [17] reported that an intraoperative diagnosis is missed in up to 50% of patients. Some patients have been found to have extensive pelvic tumor, perhaps manifested by a tubo-ovarian mass.…”

Section: Clinical Manifestationsmentioning

confidence: 99%

“…On routine lymphadenectomy, 42%-59% of patients show lymph node metastases, with almost equal involvement of the para-aortic and pelvic lymph nodes [34]. Compared with EOC, nodal spread is more common in PFTC, and therefore these observations provide the basis for recommending lymph node sampling as a mandatory procedure of surgical staging [28,48]. Surgical understaging, as in the case of EOC, was common in older series.…”

Section: Pathologymentioning

confidence: 99%

“…Radiotherapy could possibly be considered either as adjuvant therapy for early-stage patients [2,5,28,45,46,73,85,[93][94][95][96], for stage III residual negative patients, or in the relapse setting. Although radiotherapy has been used traditionally in the past as an adjuvant therapy for PFTC, its role in the era of effective chemotherapy is less well defined and controversial.…”

Section: Radiotherapymentioning

confidence: 99%

“…Some cases of occult PFTC have been detected at prophylactic salpingo-oophorectomy in BRCA-1 mutation carriers [27]. Therefore, the risk for this malignancy should be considered when prophylactic surgery is performed in such high-risk women [28]. In the case of prophylactic surgery, the uterus and the intrauterine portion of the fallopian tube should be removed.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Fallopian Tube Carcinoma: A Review

2006

View full text Add to dashboard Cite

Purpose. Primary fallopian tube carcinoma (PFTC) is a rare tumor that histologically and clinically resembles epithelial ovarian cancer (EOC). The purpose of this study is to review the current available literature data on PFTC.Patients and Results. Early clinical manifestation and prompt investigation often lead to diagnosis at an early stage of disease. However, the diagnosis of PFTC is rarely considered preoperatively and is usually first appreciated by the pathologist. Surgical staging/management and the use of chemotherapy follow the concepts used in epithelial ovarian cancer (EOC). In contrast to EOC is the importance of early lymphatic spread in this disease. The earlier diagnosis of PFTC leads to an apparent better survival compared with EOC. However, as with EOC, stage and residual tumor are the most important prognostic variables.Conclusion. Until more extensive clinical research has been performed, ovarian carcinoma management principles should be used in clinical practice. The Oncologist 2006;11:902-912

show abstract

Section: Clinical Manifestationsmentioning

confidence: 99%

Section: Pathologymentioning

confidence: 99%

Section: Radiotherapymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Fallopian Tube Carcinoma: A Review

2006

View full text Add to dashboard Cite

show abstract

“…9,10 Tubal karsinomlu olguların %80'inde serum CA-125 seviyeleri yüksek saptanabilmektedir. 10,11 Hefler ve ark., primer tubal karsinomlu olgularda ortalama CA-125 değerini 183 U/mL olarak tespit etmişlerdir. 12 Yeni çalışmalarla desteklenmemiş olsa da B-hCG değerinin de marker olabileceği belirtilmiş.…”

Section: Discussionunclassified

Primary Fallopian Cancer as an Incidental Finding: Case Report

Anğın¹,

Apı²,

Polat³

et al. 2015

Turkiye Klinikleri J Gynecol Obst

View full text Add to dashboard Cite

Cancer of the Ovary and F allopian Tube

2014

View full text Add to dashboard Cite

Ovarian Cancer In both treatment and management of carcinoma of the ovary, a series of endpoints has been identified. Such endpoints are widely mentioned in the literature and will be analyzed in this chapter by following the guidelines suggested in the first part of this book, “Principles of Prognostic Factors.” Overall, the probability of cure of ovarian cancer is low, 41.6% 5‐year survival (Volume 23 of the FIGO Annual Report on the Results of Treatment in Gynecological Cancer ), even though in the last 20 years it has increased at least by one third. The improvement of overall survival thus represents the main objective of prospective clinical research, with study designs derived from the results obtained in other fields of clinical and basic research. The different prognostic factors are discussed according to their subdivision into essential, additional , and new and promising . Each of these factors will be cross‐referenced to tumor‐, host‐ and environment‐related characteristics, although some of them cannot be strictly classified under these specific categories. Prognostic factors will be dealt with in four different scenarios , chosen according to the importance they have in the management of this cancer.

show abstract

Primary adenocarcinoma of the fallopian tube. Review of the literature

Cited by 50 publications

References 40 publications

Fallopian Tube Carcinoma: A Review

Fallopian Tube Carcinoma: A Review

Primary Fallopian Cancer as an Incidental Finding: Case Report

Cancer of the Ovary and F allopian Tube

Contact Info

Product

Resources

About